Emerging Trends and their Impacts on Peptic Ulcer Diseases: Treatments and Techniques

被引:0
|
作者
Singh, Pranjal Kumar [1 ]
Easwari, T. S. [1 ]
机构
[1] IIMT Univ, IIMT Coll Med Sci, Dept Pharmaceut, Meerut 201012, Uttar Pradesh, India
关键词
Peptic ulcer; proton pump inhibitor; perforation; acidity; dyspepsia; NSAIDs; H; pylori; PROTON-PUMP INHIBITORS; HELICOBACTER-PYLORI; RISK-FACTORS; IN-VIVO; PATHOGENESIS; PREVENTION; INTEGRITY; DIAGNOSIS; HISTORY;
D O I
10.2174/1574885517666220307115813
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Peptic ulcer disease (PUD) is prevalent in almost all parts of the world. PUD complications are a major source of health care expenses; however, they are preventable. The major factors responsible for the incidence of PUD and its complication have changed over the past few decades after the identification of non-steroidal inflammatory drugs (NSAIDs) and Helicobacter pylori bacterial infection along with a marked increase in the use of proton-pump inhibitors (PPIs) as drug therapy. The management of PUD has become more complex and challenging due to antimicrobial resistance. Objectives: The objective of the study was to highlight current therapy and novel techniques used in the treatment of peptic ulcer diseases. Methods: An exhaustive literature search has been conducted across PubMed, Google, Scopus and Web of Science electronic databases to extract the crucial information from the relevant literature. Results: In the present review, we have discussed PUD and its pathophysiology. The recent trends in PUD and possible treatments with novel techniques have also been discussed. The type and presence of ulcers cannot be predicted accurately based on symptoms. The available treatment approaches for peptic ulcers based on their clinical presentation and etiology are anti-secretory therapy, endoscopy to reveal ulcers, followed by drug therapy, and triple therapy for H. pylori infection. Conclusion: Thus, the popular and effective methods are very beneficial in controlling PUD. The treatment based on diagnosis is the foremost requirement for ameliorating any disorder. In this article, the emerging techniques and advancements in the treatment and diagnosis of PUD have been reviewed.
引用
收藏
页码:2 / 11
页数:10
相关论文
共 50 条
  • [31] Rising trends of gastric cancer and peptic ulcer in the 19th century
    Sonnenberg, A.
    Baron, J. H.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2010, 32 (07) : 901 - 907
  • [32] Critical evaluation of the treatment of peptic ulcer diseases associated with Helicobacter pylori infection
    Gabryelewicz, A
    JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1996, 47 (01): : 51 - 58
  • [33] Inverse time trends of peptic ulcer and reflux esophagitis show significant association with reduced prevalence ofHelicobacter pyloriinfection
    Yamamichi, Nobutake
    Yamaji, Yutaka
    Shimamoto, Takeshi
    Takahashi, Yu
    Majima, Kenichiro
    Wada, Ryoichi
    Mitsushima, Tohru
    Koike, Kazuhiko
    ANNALS OF MEDICINE, 2020, 52 (08) : 506 - 514
  • [34] Genome-wide Mendelian randomization identifies putatively causal gut microbiota for multiple peptic ulcer diseases
    Zhao, Jingwei
    Hou, Yucheng
    Xie, Tianyi
    Zhu, Yizhang
    Feng, Xinyi
    Zhang, Yong
    Yang, Ziyi
    Gong, Wei
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [35] Glycosaminoglycan Therapy for Bladder Diseases: Emerging New Treatments
    Bassi, Pier Francesco
    Costantini, Elisabetta
    Foley, Steve
    Palea, Stefano
    EUROPEAN UROLOGY SUPPLEMENTS, 2011, 10 (06) : 451 - 459
  • [36] Efficacy and safety of Hou Gu Mi Xi for peptic ulcer diseases Study protocol for a randomized controlled trial
    Chen, Xiaofan
    Yan, Dongmei
    Fang, Jianhe
    Liu, Wenjun
    Nie, Heyun
    Lv, Nonghua
    Fang, Nian
    Gong, Jinhua
    Yu, Jianwei
    Jiang, Yiping
    Liu, Zhijun
    Gan, Huihu
    Fu, Ying
    Yang, Deping
    Xiong, Yan
    Liu, Dunju
    Chen, Ming
    Wang, Yanping
    Wang, Yang
    Sun, Xin
    Zhou, Xu
    Zhu, Weifeng
    MEDICINE, 2019, 98 (29)
  • [37] Bibliometric and visualisation analyses of gastric ulcer knowledge areas and emerging trends, 2004-2024
    Liu, Zijian
    Liu, Yi
    Li, Yang
    Sun, Yuyan
    Song, Xiaoxiang
    Chen, Lu
    Zhou, Dan
    FRONTIERS IN MEDICINE, 2025, 12
  • [38] Changing pattern of antimicrobial resistance of Helicobacter pylori in Korean patients with peptic ulcer diseases
    Eun, CS
    Han, DS
    Park, JY
    Jeon, YC
    Hahm, JS
    Kim, KS
    Kang, JO
    JOURNAL OF GASTROENTEROLOGY, 2003, 38 (05) : 436 - 441
  • [39] SERUM-ALBUMIN METABOLISM IN RHEUMATIC DISEASES - RELATIONSHIP TO CORTICOSTEROIDS AND PEPTIC-ULCER
    NIWA, Y
    IIO, A
    NIWA, G
    SAKANE, T
    TSUNEMATSU, T
    KANOH, T
    JOURNAL OF CLINICAL & LABORATORY IMMUNOLOGY, 1990, 31 (01) : 11 - 16
  • [40] NFKB2 gene expression in patients with peptic ulcer diseases and gastric cancer
    Żebrowska-Nawrocka Marta
    Wosiak Agnieszka
    Pietrzak Jacek
    Agnieszka Jeleń
    Krygier Adrian
    Szmajda-Krygier Dagmara
    Aleksandra Sałagacka-Kubiak
    Ewa Balcerczak
    Molecular Biology Reports, 2020, 47 : 2015 - 2021